Neo Ivy Capital Management

Position in MRK — Merck & Co., Inc.

CIK 1727783 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$400,791

-$368,485 QoQ

Shares Held

3,119

-67.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#2,880

of 3,769 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $8,085,964 across 5 Drug Manufacturers - General names. MRK ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	144,562	$3,481,052
2	BMY	Bristol Myers Squibb Co	54,404	$3,134,758
3	ABBV	AbbVie Inc.	3,502	$881,243
4	MRK	Merck & Co., Inc. This page	3,119	$400,791
5	GILD	Gilead Sciences, Inc.	1,489	$188,120

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$400,791	3,119	-67.9%	Shares	Sole	2026-08-14
2025-06-30	$769,276	9,718	-78.5%	Shares	Sole	2025-08-12
2025-03-31	$4,061,460	45,248	+66.6%	Shares	Sole	2025-05-06
2024-12-31	$2,702,374	27,165	-20.9%	Shares	Sole	2025-02-18
2024-09-30	$3,898,514	34,330	+1756.7%	Shares	Sole	2024-11-18
2022-09-30	$159,235	1,849	-29.5%	Shares	Sole	2022-11-16
2022-06-30	$239,047	2,622	-79.1%	Shares	Sole	2022-08-16
2022-03-31	$1,031,696	12,574	+124.7%	Shares	Sole	2022-05-16
2021-12-31	$428,877	5,596	+32.6%	Shares	Sole	2022-02-15
2020-03-31	$324,609	4,219	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.